A regenerative treatment is needed to reverse age-related loss of corneal endothelial cells (CEC). A significant opportunity awaits the company that delivers an effective treatment. Corneal ...
In this Healio Video Perspective from Hawaiian Eye 2025, Greg Kunst, CEO of Aurion Biotech, discusses positive phase 1/2 data for the company’s cell therapy for corneal endothelial disease.
In 2022, doctors in Japan performed a transplant of iPS cell-derived corneal endothelial cells iPS cell derived-corneal endothelial cell transplants are injected and take about 20 minutes In Japan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results